-
1
-
-
0017862649
-
Sulfinpyrazone in the prevention of cardiac death after myocardial infarction: the Anturane Reinfarction Trial
-
Anturane Reinfarction Trial Research Group: Sulfinpyrazone in the prevention of cardiac death after myocardial infarction: the Anturane Reinfarction Trial. N Engl J Med 298: 289–295, 1978
-
(1978)
N Engl J Med
, vol.298
, pp. 289-295
-
-
-
2
-
-
0017137743
-
Aspirin in coronary heart disease
-
The Coronary Drug Project Research Group: Aspirin in coronary heart disease. J Chronic Dis 29: 625–642, 1976
-
(1976)
J Chronic Dis
, vol.29
, pp. 625-642
-
-
-
3
-
-
0015956225
-
A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction
-
Elwood PC, Cochrane AL, Burr ML, et al: A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J 1: 436–440, 1974
-
(1974)
Br Med J
, vol.1
, pp. 436-440
-
-
Elwood, P.C.1
Cochrane, A.L.2
Burr, M.L.3
-
4
-
-
0040321220
-
The discovery of prostacyclin — a fresh insight into arachiconic acid metabolism, Biochemical Aspects of Prostaglandins and Thromboxanes
-
Edited by N Kharasch, J Fried. New York, Academic Press
-
Moncada S, Vane JR: The discovery of prostacyclin — a fresh insight into arachiconic acid metabolism, Biochemical Aspects of Prostaglandins and Thromboxanes. Edited by N Kharasch, J Fried. New York, Academic Press, 1977, pp 155–177
-
(1977)
, pp. 155-177
-
-
Moncada, S.1
Vane, J.R.2
-
6
-
-
0017893621
-
Inhibition of platelet prostaglandin synthetase by oral aspirin
-
Burch JW, Stanford N, Majerus PW: Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest 61: 314–319, 1978
-
(1978)
J Clin Invest
, vol.61
, pp. 314-319
-
-
Burch, J.W.1
Stanford, N.2
Majerus, P.W.3
-
7
-
-
0018088932
-
Sensitivity of fatty acid cyclo-oxygenase from human aorta to acetylation by aspirin
-
Burch JW, Baenziger NL, Stanford N, et al: Sensitivity of fatty acid cyclo-oxygenase from human aorta to acetylation by aspirin. Proc Natl Acad Sci USA 75: 5181–5184, 1978
-
(1978)
Proc Natl Acad Sci USA
, vol.75
, pp. 5181-5184
-
-
Burch, J.W.1
Baenziger, N.L.2
Stanford, N.3
-
8
-
-
0018745134
-
Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells, and skin fibroblasts
-
Baenziger NL, Becherer PR, Majerus PW: Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells, and skin fibroblasts. Cell 16: 967–974, 1979
-
(1979)
Cell
, vol.16
, pp. 967-974
-
-
Baenziger, N.L.1
Becherer, P.R.2
Majerus, P.W.3
-
9
-
-
0016805004
-
The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particular fraction protein
-
Roth GJ, Majerus PW: The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particular fraction protein. J Clin Invest 56: 624–632, 1975
-
(1975)
J Clin Invest
, vol.56
, pp. 624-632
-
-
Roth, G.J.1
Majerus, P.W.2
-
10
-
-
0016386365
-
Arteriovenous-shunt thrombosis: prevention by sulfinpyrazone
-
Kaegi A, Pineo GF, Shimizu A, et al: Arteriovenous-shunt thrombosis: prevention by sulfinpyrazone. N Engl J Med 290: 304–306, 1974
-
(1974)
N Engl J Med
, vol.290
, pp. 304-306
-
-
Kaegi, A.1
Pineo, G.F.2
Shimizu, A.3
-
11
-
-
0014205722
-
Reduction of clotting in Scribner shunts by long-term anticoagulation
-
Wing AJ, Curtis JR, De Wardener HE: Reduction of clotting in Scribner shunts by long-term anticoagulation. Br Med J 3: 143–145, 1967
-
(1967)
Br Med J
, vol.3
, pp. 143-145
-
-
Wing, A.J.1
Curtis, J.R.2
De Wardener, H.E.3
-
12
-
-
0016802131
-
The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis
-
Kaegi A, Pineo GF, Shimizu A, et al: The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis. Circulation 52: 497–499, 1975
-
(1975)
Circulation
, vol.52
, pp. 497-499
-
-
Kaegi, A.1
Pineo, G.F.2
Shimizu, A.3
-
13
-
-
0017669249
-
Aspirin prophylaxis of venous thromboembolism after total hip replacement
-
Harris WH, Salzman EW, Athanasoulis CA, et al: Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med 297: 1246–1249, 1977
-
(1977)
N Engl J Med
, vol.297
, pp. 1246-1249
-
-
Harris, W.H.1
Salzman, E.W.2
Athanasoulis, C.A.3
-
15
-
-
0014955507
-
External arteriovenous shunts for intermittent long-term hemodialysis: five years’ experience
-
Farooki MS, Gergely NF, McAninch LN: External arteriovenous shunts for intermittent long-term hemodialysis: five years’ experience. Can Med Assoc J 103: 1371–1374, 1970
-
(1970)
Can Med Assoc J
, vol.103
, pp. 1371-1374
-
-
Farooki, M.S.1
Gergely, N.F.2
McAninch, L.N.3
-
16
-
-
0014747545
-
Radiological contrast study of arteriovenous dialysis cannulae
-
Cohen BH, Chinitz JL, Soll KH: Radiological contrast study of arteriovenous dialysis cannulae. Radiology 94: 603–606, 1970
-
(1970)
Radiology
, vol.94
, pp. 603-606
-
-
Cohen, B.H.1
Chinitz, J.L.2
Soll, K.H.3
-
18
-
-
0014263439
-
A histological examination of veins used in artificial arteriovenous (‘Quinton/Scribner’) shunts
-
Glashan RW, Walker F: A histological examination of veins used in artificial arteriovenous (‘Quinton/Scribner’) shunts. Br J Surg 55: 189–193, 1968
-
(1968)
Br J Surg
, vol.55
, pp. 189-193
-
-
Glashan, R.W.1
Walker, F.2
-
19
-
-
0018145841
-
Aspirin: a paradoxical effect on bleeding-time
-
O'Grady J, Moncada S: Aspirin: a paradoxical effect on bleeding-time. Lancet 2: 780, 1978
-
(1978)
Lancet
, vol.2
, pp. 780
-
-
O'Grady, J.1
Moncada, S.2
|